• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结膜松弛症作为药物治疗青光眼患者眼表疾病发生的一个促成因素。

Conjunctivochalasis as a contributing factor for the development of ocular surface disease in medically treated glaucoma patients.

作者信息

Kocabeyoglu Sibel, Mocan Mehmet C, Irkec Murat, Orhan Mehmet, Karakaya Jale

机构信息

Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.

出版信息

J Glaucoma. 2014 Jun-Jul;23(5):333-6. doi: 10.1097/IJG.0b013e3182741f32.

DOI:10.1097/IJG.0b013e3182741f32
PMID:23377585
Abstract

PURPOSE

To evaluate the impact of conjunctivochalasis (CCh) and its severity on the ocular surface parameters of glaucoma subjects treated with topical antiglaucomatous medication.

MATERIALS AND METHODS

One hundred patients with the clinical diagnosis of glaucoma were recruited for this study. CCh was graded based on the extent of inferior lid margin involvement as follows: 1=single (temporal) location, 2=two locations (nasal and temporal), and 3=whole lid. For all the subjects, the break-up time (BUT), lissamine green (LG) staining, and Schirmer test (under topical anesthesia) was performed for both eyes. Ocular Surface Disease Index (OSDI) questionnaire scores were also noted for each subject. Student t test, Mann-Whitney U test, and Kruskal-Wallis test was used for statistical evaluations.

RESULTS

Sixty-three subjects had evidence of CCh; 32 had grade 1, 24 had grade 2, 7 had grade 3 CCh, and 37 glaucoma patients had no evidence of CCh. There were significant differences in the BUT scores (7.2±2.7 vs. 10.1±2.4 s, P<0.001), Schirmer values (7.7±3.9 vs. 13.3.±4.0 mm, P<0.001), LG staining score (1.6±1.0 vs. 0.3±0.5, P<0.001), and the OSDI scores (19.4±17.2 vs. 6.7±5.2, P<0.001) between patients who had CCh and those without CCh. The BUT scores and Schirmer test values of patients with grades 2 and 3 CCh were significantly lower than those of grade 1 CCh and those without CCh (P<0.001). The LG grading and OSDI scores were significantly higher in grade 2 and 3 patients as compared with those with grade 1 CCh and those without CCh (P<0.001).

CONCLUSIONS

The functional characteristics of the ocular surface appear to be adversely influenced by the presence and the extent of CCh in glaucoma patients.

摘要

目的

评估结膜松弛症(CCh)及其严重程度对局部使用抗青光眼药物治疗的青光眼患者眼表参数的影响。

材料与方法

本研究招募了100例临床诊断为青光眼的患者。根据下睑缘受累程度对CCh进行分级,如下:1级=单个(颞侧)部位,2级=两个部位(鼻侧和颞侧),3级=整个眼睑。对所有受试者的双眼进行泪膜破裂时间(BUT)、丽丝胺绿(LG)染色和泪液分泌试验(表面麻醉下)。还记录了每个受试者的眼表疾病指数(OSDI)问卷得分。采用学生t检验、曼-惠特尼U检验和克鲁斯卡尔-沃利斯检验进行统计学评估。

结果

63例受试者有CCh证据;32例为1级,24例为2级,7例为3级CCh,37例青光眼患者无CCh证据。有CCh和无CCh的患者在BUT得分(7.2±2.7秒对10.1±2.4秒,P<0.001)、泪液分泌试验值(7.7±3.9毫米对13.3±4.0毫米,P<0.001)、LG染色评分(1.6±1.0对0.3±0.5,P<0.001)和OSDI得分(19.4±17.2对6.7±5.2,P<0.001)方面存在显著差异。2级和3级CCh患者的BUT得分和泪液分泌试验值显著低于1级CCh患者和无CCh患者(P<0.001)。与1级CCh患者和无CCh患者相比,2级和3级患者的LG分级和OSDI得分显著更高(P<0.001)。

结论

青光眼患者中CCh的存在及其程度似乎会对眼表的功能特征产生不利影响。

相似文献

1
Conjunctivochalasis as a contributing factor for the development of ocular surface disease in medically treated glaucoma patients.结膜松弛症作为药物治疗青光眼患者眼表疾病发生的一个促成因素。
J Glaucoma. 2014 Jun-Jul;23(5):333-6. doi: 10.1097/IJG.0b013e3182741f32.
2
Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.局部青光眼治疗与眼表疾病:一项前瞻性对照队列研究。
Can J Ophthalmol. 2015 Apr;50(2):132-6. doi: 10.1016/j.jcjo.2014.11.006.
3
Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.使用局部降眼压药物的青光眼患者的眼表不适患病率。
Cornea. 2010 Jun;29(6):618-21. doi: 10.1097/ICO.0b013e3181c325b2.
4
New approach for conjunctivochalasis using an argon green laser.采用氩绿激光治疗结膜松弛症的新方法。
Cornea. 2013 May;32(5):574-8. doi: 10.1097/ICO.0b013e318255eaaa.
5
Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.长期使用青光眼药物患者的睑板腺功能障碍
Cornea. 2016 Aug;35(8):1112-6. doi: 10.1097/ICO.0000000000000838.
6
Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion.结膜松弛症患者泪液清除延迟与泪点阻塞有关。
Cornea. 2007 Apr;26(3):290-3. doi: 10.1097/ICO.0b013e31802e1e24.
7
Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.青光眼患者的眼表疾病:联合用药及防腐剂的影响
Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542.
8
The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.青光眼药物对合并或不合并结膜松弛的原发性开角型青光眼患者眼表疾病的影响。
Acta Ophthalmol. 2014 Nov;92(7):e592-3. doi: 10.1111/aos.12425. Epub 2014 Apr 28.
9
Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis.结膜松弛症患者泪液中白细胞介素-6和白细胞介素-8水平升高。
Cornea. 2009 Feb;28(2):189-93. doi: 10.1097/ICO.0b013e3181861d0c.
10
Prevalence of ocular surface disease in glaucoma patients.青光眼患者眼表疾病的患病率。
J Glaucoma. 2008 Aug;17(5):350-5. doi: 10.1097/IJG.0b013e31815c5f4f.

引用本文的文献

1
Clinical correlations and ımpact of conjunctivochalasis in soft contact lens wearers.临床相关性和软性隐形眼镜佩戴者结膜松弛症的影响。
Int Ophthalmol. 2024 Feb 9;44(1):39. doi: 10.1007/s10792-024-02936-x.
2
Characteristics of tear meniscus using a spectral domain optical coherence tomography in medically controlled glaucoma.在医学控制的青光眼患者中使用谱域光学相干断层扫描测量泪膜新月形的特征。
Indian J Ophthalmol. 2023 Jul;71(7):2704-2710. doi: 10.4103/IJO.IJO_2653_22.
3
Treatment outcomes of modified argon laser photocoagulation for conjunctivochalasis.
改良氩激光光凝治疗结膜松弛症的疗效观察。
Medicine (Baltimore). 2023 Jan 13;102(2):e32633. doi: 10.1097/MD.0000000000032633.
4
Ocular Surface Disease and Glaucoma Medications: A Clinical Approach.眼表疾病与青光眼用药:临床治疗方法
Eye Contact Lens. 2019 Jan;45(1):11-18. doi: 10.1097/ICL.0000000000000544.